Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...

The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to ...

Chronic pain is defined as experiencing discomfort ... CBD for Pain While additional research is needed, using CBD for pain management may have a number of benefits, including: Despite these ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

In an international effort, researchers at Western, the University of Maryland School of Dentistry (UMSOD) and Neuroscience ...

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

New research from McGill University reveals that listening to music at your own rhythm can significantly reduce pain.

Experts with the Cleveland Clinic say the drug has a lot of potential, especially since it is considered nonaddictive.

Journavx, a new non-opioid pain medication, offers a safer alternative for managing acute pain while reducing the risk of ...

Yale researchers found that cannabis-derived compounds CBD, CBG and CBN reduce pain signaling by inhibiting the Nav1.8 ...

New research reveals how CBD and THC interact with brain receptors, unlocking potential for safer cannabis-based treatments.

Between 40% to 70% of veterans suffer from chronic pain, and back pain is most commonly reported ... The new study appears in ...